Investigating a specific receptor in pituitary tumors to improve treatment planning.
Somatostatin Receptor 2 Expression in Pituitary Neuroendocrine Tumors as a Basis for PET/MRI guided Subtype Stratification and Radiotherapy Planning
This study is looking at a common type of brain tumor called pituitary neuroendocrine tumors to see how a specific receptor can help doctors better understand the disease after surgery, with the goal of improving radiation therapy for patients who still have tumor left.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11115111 on NIH RePORTER |
What this research studies
This research focuses on pituitary neuroendocrine tumors (pitNET), which are a common type of brain tumor. It aims to better understand the expression of somatostatin receptor 2 (SSTR2) in these tumors, which can help in accurately identifying the extent of the disease after surgery. By using advanced imaging techniques like PET/MRI, the study seeks to improve the planning of radiation therapy for patients who have not been cured by surgery. This approach could lead to more effective treatment options for patients with residual tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pituitary neuroendocrine tumors who have residual disease after surgery.
Not a fit: Patients with pituitary tumors that have been completely removed or those who do not express somatostatin receptor 2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for patients with pituitary tumors by enhancing the accuracy of tumor targeting during radiation therapy.
How similar studies have performed: Previous research has shown promising results using similar imaging techniques to improve treatment planning for brain tumors, indicating potential success for this approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Ivanidze, Jana — Weill Medical Coll of Cornell Univ
- Study coordinator: Ivanidze, Jana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.